| abstract |
The present invention discloses a compound of formula I or a pharmaceutically acceptable salt thereof and is useful as a CCR5 antagonist. Also disclosed are processes and uses for the compounds of formula I and drug compositions containing the compounds of formula I. In addition, intermediates useful for the preparation of compounds of formula I are disclosed. |